Spectral AI Adds Additional Clinical Sites to MultiCenter Diabetic Foot Ulcer DFU Study

Spectral AI Adds Additional Clinical Sites to MultiCenter Diabetic Foot Ulcer DFU Study

DALLAS, Oct. 16, 2023 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI; MDAIW) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the addition of seven clinical sites that are currently enrolling to…Read More

Leave a Reply

Your email address will not be published. Required fields are marked *